Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Influence of depression on breast cancer treatment and survival: A Kentucky population-based study.
Journal: Cancer
Published: June 08, 2022
Adjuvant Treatment of Triple-Negative Metaplastic Breast Cancer With Weekly Paclitaxel and Platinum Chemotherapy: Retrospective Case Review From a Single Institution.
Journal: Clinical breast cancer
Published: February 14, 2019
Medical oncologists' perception of antiestrogen therapy benefit in premenopausal women with hormone receptor-positive early-stage breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 07, 2017
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 27, 2017
Trastuzumab use in patients with durable complete response in HER2-amplified metastatic breast cancer: to continue or not to continue.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 27, 2017
Systemic therapy for HER2-positive early-stage breast cancer.
Journal: Current problems in cancer
Published: August 30, 2016
Time-Varying Effects of Breast Cancer Adjuvant Systemic Therapy.
Journal: Journal of the National Cancer Institute
Published: May 08, 2015
Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: April 16, 2015
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 22, 2014
Impact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast cancer disease characteristics: implications for tumor biology and research.
Journal: Breast cancer research and treatment
Published: August 29, 2014
Everolimus-induced hematologic changes in patients with metastatic breast cancer.
Journal: Clinical breast cancer
Published: May 20, 2014
Last Updated: 09/26/2026